Cargando…

Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids

Nanotechnology has opened up a new, previously unimaginable world in cancer diagnosis and therapy, leading to the emergence of cancer nanomedicine and nanoparticle-aided radiotherapy. Smart nanomaterials (nanoparticle drones) can now be constructed with capability to precisely target cancer cells an...

Descripción completa

Detalles Bibliográficos
Autores principales: Ngwa, Wilfred, Kumar, Rajiv, Moreau, Michele, Dabney, Raymond, Herman, Allen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609560/
https://www.ncbi.nlm.nih.gov/pubmed/28971063
http://dx.doi.org/10.3389/fonc.2017.00208
_version_ 1783265631694487552
author Ngwa, Wilfred
Kumar, Rajiv
Moreau, Michele
Dabney, Raymond
Herman, Allen
author_facet Ngwa, Wilfred
Kumar, Rajiv
Moreau, Michele
Dabney, Raymond
Herman, Allen
author_sort Ngwa, Wilfred
collection PubMed
description Nanotechnology has opened up a new, previously unimaginable world in cancer diagnosis and therapy, leading to the emergence of cancer nanomedicine and nanoparticle-aided radiotherapy. Smart nanomaterials (nanoparticle drones) can now be constructed with capability to precisely target cancer cells and be remotely activated with radiation to emit micrometer-range missile-like electrons to destroy the tumor cells. These nanoparticle drones can also be programmed to deliver therapeutic payloads to tumor sites to achieve optimal therapeutic efficacy. In this article, we examine the state-of-the-art and potential of nanoparticle drones in targeting lung cancer. Inhalation (INH) (air) versus traditional intravenous (“sea”) routes of navigating physiological barriers using such drones is assessed. Results and analysis suggest that INH route may offer more promise for targeting tumor cells with radiosensitizers and cannabinoids from the perspective of maximizing damage to lung tumors cells while minimizing any collateral damage or side effects.
format Online
Article
Text
id pubmed-5609560
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-56095602017-10-02 Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids Ngwa, Wilfred Kumar, Rajiv Moreau, Michele Dabney, Raymond Herman, Allen Front Oncol Oncology Nanotechnology has opened up a new, previously unimaginable world in cancer diagnosis and therapy, leading to the emergence of cancer nanomedicine and nanoparticle-aided radiotherapy. Smart nanomaterials (nanoparticle drones) can now be constructed with capability to precisely target cancer cells and be remotely activated with radiation to emit micrometer-range missile-like electrons to destroy the tumor cells. These nanoparticle drones can also be programmed to deliver therapeutic payloads to tumor sites to achieve optimal therapeutic efficacy. In this article, we examine the state-of-the-art and potential of nanoparticle drones in targeting lung cancer. Inhalation (INH) (air) versus traditional intravenous (“sea”) routes of navigating physiological barriers using such drones is assessed. Results and analysis suggest that INH route may offer more promise for targeting tumor cells with radiosensitizers and cannabinoids from the perspective of maximizing damage to lung tumors cells while minimizing any collateral damage or side effects. Frontiers Media S.A. 2017-09-19 /pmc/articles/PMC5609560/ /pubmed/28971063 http://dx.doi.org/10.3389/fonc.2017.00208 Text en Copyright © 2017 Ngwa, Kumar, Moreau, Dabney and Herman. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Ngwa, Wilfred
Kumar, Rajiv
Moreau, Michele
Dabney, Raymond
Herman, Allen
Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids
title Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids
title_full Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids
title_fullStr Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids
title_full_unstemmed Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids
title_short Nanoparticle Drones to Target Lung Cancer with Radiosensitizers and Cannabinoids
title_sort nanoparticle drones to target lung cancer with radiosensitizers and cannabinoids
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5609560/
https://www.ncbi.nlm.nih.gov/pubmed/28971063
http://dx.doi.org/10.3389/fonc.2017.00208
work_keys_str_mv AT ngwawilfred nanoparticledronestotargetlungcancerwithradiosensitizersandcannabinoids
AT kumarrajiv nanoparticledronestotargetlungcancerwithradiosensitizersandcannabinoids
AT moreaumichele nanoparticledronestotargetlungcancerwithradiosensitizersandcannabinoids
AT dabneyraymond nanoparticledronestotargetlungcancerwithradiosensitizersandcannabinoids
AT hermanallen nanoparticledronestotargetlungcancerwithradiosensitizersandcannabinoids